Penbrook Management’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$500K Sell
5,200
-74,315
-93% -$6.79M 0.32% 64
2026
Q1
$2.95M Sell
79,515
-35,385
-31% -$1.13M 2.23% 9
2025
Q4
$2.32M Sell
114,900
-1,350
-1% -$32.7K 1.6% 13
2025
Q3
$3.5M Sell
116,250
-51,375
-31% -$1.11M 2.44% 9
2025
Q2
$1.93M Buy
167,625
+126,250
+305% +$1.2M 0.73% 38
2025
Q1
$302K Buy
41,375
+7,550
+22% +$83.5K 0.23% 84
2024
Q4
$563K Buy
33,825
+6,825
+25% +$91K 0.38% 55
2024
Q3
$347K Sell
27,000
-580
-2% -$8.39K 0.23% 75
2024
Q2
$308K Buy
+27,580
New +$321K 0.19% 77
2024
Q1
Sell
-8,080
Closed -$214K 103
2023
Q4
$214K Buy
+8,080
New +$236K 0.14% 90

Other funds holding AEHR

Penbrook Management's AEHR Position: Q2 2026 in Review

Penbrook Management reduced its Aehr Test Systems (AEHR) stake by 93% in Q2 2026, selling an estimated $6.79M and leaving 5,200 shares worth $500K. The position accounts for 0.32% of the portfolio, ranked #64.

Penbrook Management first reported a position in AEHR in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.5M in Q3 2025. 53 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Penbrook Management held 5,200 shares of Aehr Test Systems worth $500K as of Q2 2026.
  • Penbrook Management sold 74,315 Aehr Test Systems shares in Q2 2026, an estimated $6.79M.
  • Aehr Test Systems made up 0.32% of Penbrook Management's portfolio in Q2 2026, its #64 holding.
  • Penbrook Management first reported a position in Aehr Test Systems in Q4 2023 and has held it in 10 quarters since.
  • Penbrook Management's Aehr Test Systems position peaked at $3.5M in Q3 2025.
  • 53 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Penbrook Management's 13F filing for Q2 2026, filed 23 Jul 2026.